-
African-American girls from low-income neighborhoods who have had childhood violence exposure are significantly more likely to engage in high-risk sexual activities, researchers found.
-
New research suggests that roughly half of HIV patients might have some neurocognitive impairment, although most of this might be asymptomatic or mild.
-
Researchers continue to study the neurological processes impacting HIV-associated neurocognitive disorder (HAND), finding most recently that an inflammatory marker called osteopontin stimulates HIV replication and remains in the central nervous system despite antiretroviral therapy.
-
The Joint Commission targets central lineassociated bloodstream infections in its 2011 national patient safety goals, with NPSG.07.04.01 calling for hospitals to "implement evidence-based practices to prevent (CLABSIs)."
-
In selected data analysis for 2007, most people with HIV infection who were receiving medical care were taking antiretroviral therapy and had some form of health insurance or coverage, the Centers for Disease Control and Prevention reports.
-
-
In this issue: ACEI/ARB therapy for AS; safety alert issued for dronedarone; statins and cancer risk; nesiritide and heart failure; and FDA actions.
-
The association of HPV infection and bladder cancer has been a topic of discussion for the last decade, but has not surfaced because of important other outcomes of HPV infection. HPV is increasing in its prevalence globally and its chronic nature raises many issues in and around the genital tract.
-
Herrera and colleagues reviewed the use of interferon-ã release assays (IGRAs) for the diagnosis of latent tuberculosis infection (LTBI).
-
A total of 1,763 HIV-1 serodiscordant couples in nine countries with the infected partner having CD4+ counts of 350-500/mL were randomized 1:1 to early (immediate) vs. delayed (CD4+ had declined to ¡Ü 250/mL or after development of an AIDS-related illness) antiretroviral therapy of the infected partner.